Related Experiment Video
Updated: May 27, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
Published on: July 16, 2012
Recombination in hepatitis C virus
Fernando González-Candelas1, F Xavier López-Labrador, María Alma Bracho
1Unidad Mixta "Genómica y Salud" CSISP, Instituto Cavanilles de Biodiversidad y Biología Evolutiva, Universidad de Valencia, Catedrático José Beltrán 2, E-46980 Paterna, Valencia, Spain. fernando.gonzalez@uv.es
Insights
Hepatitis C virus (HCV) recombination, where different genome segments combine, is rare but challenging to detect. Understanding this genetic diversity is crucial for developing new treatments for this global liver disease.
Area of Science:
- Virology
- Genetics
- Hepatology
Background:
- Hepatitis C virus (HCV), a Flavivirus, infects nearly 200 million globally, causing significant liver disease.
- HCV exhibits high genetic diversity, classified into six genotypes and approximately 80 subtypes, influencing clinical outcomes and treatment responses.
- Recombination in HCV, involving the exchange of genetic material between different strains, has been reported infrequently since its initial discovery in 2002.
Purpose of the Study:
- To review the literature on Hepatitis C virus recombination.
- To discuss the challenges in unequivocally establishing HCV recombination.
- To analyze the potential clinical implications of HCV recombination, particularly concerning new therapeutic strategies.
Main Methods:
- Literature review of reported cases of HCV recombination.
- Analysis of methodologies used to detect and confirm HCV recombination.
- Examination of the genetic diversity and evolutionary mechanisms of HCV.
Main Results:
- HCV recombination occurs at multiple levels: between genotypes, subtypes, and even strains within the same subtype.
- Establishing definitive evidence for HCV recombination is analytically challenging.
- The frequency and full extent of HCV recombination remain incompletely understood.
Conclusions:
- The genetic diversity of HCV, including recombination, presents challenges for accurate detection and characterization.
- Understanding HCV recombination is essential for predicting viral evolution and treatment efficacy.
- Further research into HCV recombination mechanisms and clinical impact is warranted, especially with emerging therapies.
Abstract:
Hepatitis C virus (HCV) is a Flavivirus with a positive-sense, single-stranded RNA genome of about 9,600 nucleotides. It is a major cause of liver disease, infecting almost 200 million people all over the world. Similarly to most RNA viruses, HCV displays very high levels of genetic diversity which have been used to differentiate six major genotypes and about 80 subtypes. Although the different genotypes and subtypes share basic biological and pathogenic features they differ in clinical outcomes, response to treatment and epidemiology. The first HCV recombinant strain, in which different genome segments derived from parentals of different genotypes, was described in St. Petersburg (Russia) in 2002. Since then, there have been only a few more than a dozen reports including descriptions of HCV recombinants at all levels: between genotypes, between subtypes of the same genotype and even between strains of the same subtype. Here, we review the literature considering the reasons underlying the difficulties for unequivocally establishing recombination in this virus along with the analytical methods necessary to do it. Finally, we analyze the potential consequences, especially in clinical practice, of HCV recombination in light of the coming new therapeutic approaches against this virus.
Related Concept Videos
Viral Recombination
Hepatitis
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Homologous Recombination
Homologous Recombination
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...

